RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Alliance Pharma Stock

Alliance Pharma Debt 2025

Alliance Pharma Debt

94.98 GBP

Ticker

APH.L

ISIN

GB0031030819

WKN

913253

In 2025, Alliance Pharma's total debt was 94.98 GBP, a -10.28% change from the 105.86 GBP total debt recorded in the previous year.

Alliance Pharma Aktienanalyse

What does Alliance Pharma do?

Alliance Pharma PLC is a globally operating pharmaceutical company specializing in the marketing and development of pharmaceutical products. The company is headquartered in the United Kingdom and was founded in 1996. Alliance Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Alliance Pharma's Debt Structure

Alliance Pharma's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Alliance Pharma's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Alliance Pharma’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Alliance Pharma’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Alliance Pharma stock

What is the debt of Alliance Pharma this year?

Alliance Pharma has a debt level of 94.98 GBP this year.

What was the debt of Alliance Pharma compared to the previous year?

The debt of Alliance Pharma has increased by -10.28% compared to the previous year dropped.

What are the consequences of high debt for investors in Alliance Pharma?

High debt can pose a risk for investors of Alliance Pharma, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Alliance Pharma?

Low debt means that Alliance Pharma has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Alliance Pharma affect the company?

An increase in debt of Alliance Pharma can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Alliance Pharma affect the company?

A reduction in debt of Alliance Pharma can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Alliance Pharma?

Some factors that can influence the debt of Alliance Pharma include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Alliance Pharma so important for investors?

The debts of Alliance Pharma are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Alliance Pharma take to change the debt?

To change the debt, Alliance Pharma can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Alliance Pharma pay?

Over the past 12 months, Alliance Pharma paid a dividend of 0.01 GBP . This corresponds to a dividend yield of about 1.89 %. For the coming 12 months, Alliance Pharma is expected to pay a dividend of 0.01 GBP.

What is the dividend yield of Alliance Pharma?

The current dividend yield of Alliance Pharma is 1.89 %.

When does Alliance Pharma pay dividends?

Alliance Pharma pays a quarterly dividend. This is distributed in the months of January, July, January, July.

How secure is the dividend of Alliance Pharma?

Alliance Pharma paid dividends every year for the past 0 years.

What is the dividend of Alliance Pharma?

For the upcoming 12 months, dividends amounting to 0.01 GBP are expected. This corresponds to a dividend yield of 1.88 %.

In which sector is Alliance Pharma located?

Alliance Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Alliance Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Alliance Pharma from 7/18/2023 amounting to 0.012 GBP, you needed to have the stock in your portfolio before the ex-date on 6/22/2023.

When did Alliance Pharma pay the last dividend?

The last dividend was paid out on 7/18/2023.

What was the dividend of Alliance Pharma in the year 2024?

In the year 2024, Alliance Pharma distributed 0.012 GBP as dividends.

In which currency does Alliance Pharma pay out the dividend?

The dividends of Alliance Pharma are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Alliance Pharma stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Alliance Pharma

Our stock analysis for Alliance Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alliance Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.